Basic Information
Basic information for MIR9-3HG-223-14aa
Peptide Name MIR9-3HG-223-14aa
Genome Position chr15:89388509-89388550[+]
Species Human
Peptide Sequence MTVACGLYCSRKLS
Peptide Length 14
Unique No (MIR9-3HG-201-14aa-1,MIR9-3HG-202-14aa,MIR9-3HG-203-14aa,MIR9-3HG-204-14aa,MIR9-3HG-205-14aa,MIR9-3HG-206-14aa,MIR9-3HG-207-14aa,MIR9-3HG-208-14aa,MIR9-3HG-210-14aa,MIR9-3HG-211-14aa,MIR9-3HG-212-14aa,MIR9-3HG-213-14aa,MIR9-3HG-215-14aa,MIR9-3HG-216-14aa,MIR9-3HG-217-14aa,MIR9-3HG-220-14aa,MIR9-3HG-222-14aa,MIR9-3HG-224-14aa,MIR9-3HG-225-14aa,MIR9-3HG-227-14aa,MIR9-3HG-228-14aa,MIR9-3HG-229-14aa,MIR9-3HG-230-14aa,MIR9-3HG-231-14aa,MIR9-3HG-233-14aa-1,MIR9-3HG-234-14aa,MIR9-3HG-235-14aa,MIR9-3HG-236-14aa,MIR9-3HG-237-14aa,MIR9-3HG-238-14aa,MIR9-3HG-239-14aa,MIR9-3HG-240-14aa,MIR9-3HG-241-14aa,MIR9-3HG-242-14aa,MIR9-3HG-243-14aa,MIR9-3HG-244-14aa,MIR9-3HG-245-14aa,MIR9-3HG-246-14aa,MIR9-3HG-248-14aa,MIR9-3HG-249-14aa,MIR9-3HG-250-14aa,MIR9-3HG-251-14aa,MIR9-3HG-252-14aa-2,MIR9-3HG-253-14aa)
Grand Average of Hydropathicity 0.5786
Relative Molecular Mass 1766.1
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000659850;MIR9-3HG-223
Transcript Length 1080
Coding Ability 0.5343
DNA Sequence Corresponding to Peptide ATGACTGTAGCCTGTGGATTGTACTGCAGTAGGAAACTGTCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :